US Broker Ratings

Centene Corporation (CNC): Investor Outlook Amid 10.22% Potential Upside

For investors eyeing opportunities in the healthcare sector, Centene Corporation (NYSE: CNC) presents a compelling case with a potential upside of 10.22%. As a leading player in the healthcare plans..

Solventum Corporation (SOLV) Stock Analysis: Navigating a 4.86% Potential Upside Amidst Healthcare Innovations

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is capturing investor attention with its robust portfolio of medical solutions and a notable potential upside of 4.86%. With..

Repligen Corporation (RGEN) Stock Analysis: Navigating Growth with a Robust Buy Consensus

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector specializing in medical instruments and supplies, has captured the attention of investors with its impressive market cap of $10.22..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Navigating Potential 6.58% Upside in the Biotech Sector

Revolution Medicines, Inc. (NASDAQ: RVMD), a pivotal player in the biotechnology sector, is making waves with its innovative approach to treating RAS-addicted cancers. As a clinical-stage precision oncology company, Revolution..

Baxter International Inc. (BAX) Stock Analysis: Navigating Challenges with Potential 9.06% Upside

Baxter International Inc. (NYSE: BAX) remains a noteworthy player in the healthcare sector, primarily within the Medical Instruments & Supplies industry. With a market cap of $13.62 billion, Baxter’s extensive..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a Potential 26% Upside with Strong Buy Ratings

AptarGroup, Inc. (NYSE: ATR) presents an intriguing opportunity for investors eyeing the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $8.57 billion, this..

Encompass Health Corporation (EHC) Stock Analysis: Unlocking a Potential 23% Upside

Encompass Health Corporation (NYSE: EHC), a leading entity in the Medical Care Facilities sector, presents a compelling opportunity for investors seeking growth in the healthcare industry. With a market capitalization..

Exelixis, Inc. (EXEL) Investor Outlook: Analyzing Its 44.39% Return on Equity Amidst Strong Buy Ratings

For investors looking to navigate the healthcare sector, Exelixis, Inc. (NASDAQ: EXEL) presents an intriguing opportunity within the biotechnology landscape. With its focus on oncology, specifically in the development of..

Qiagen N.V. (QGEN) Stock Analysis: Exploring Growth Potential in the Diagnostics Sector

For investors keeping an eye on the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents a compelling opportunity. As a key player in the diagnostics and research industry, Qiagen continues to..

Chemed Corp (CHE) Stock Analysis: Evaluating its Robust Growth Potential with a 2.11% Upside

Chemed Corp (NYSE: CHE), a prominent player in the healthcare sector, is drawing investor attention with its strong growth trajectory and steady financial performance. Headquartered in Cincinnati, Ohio, Chemed operates..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Unlocking a 26% Potential Upside

Intuitive Surgical, Inc. (NASDAQ: ISRG), a leading player in the healthcare sector, continues to capture investor attention with its advanced surgical technology and significant market presence. With a robust market..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating Growth Amidst a $232.67 Billion Market Cap

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, continues to capture investor attention with its robust market presence and expansive range of innovative solutions in the..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 38.67% Potential Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands out as a compelling investment opportunity in the healthcare sector, particularly in the arena of specialty and generic drug manufacturing. With a market capitalization..

IDEXX Laboratories, Inc. (IDXX) Stock Report: Analyzing a 25.50% Potential Upside for Savvy Investors

IDEXX Laboratories, Inc. (IDXX), a prominent player in the healthcare sector, specifically in diagnostics and research, presents an enticing opportunity for investors with a potential upside of 25.50%. This multinational..

Dr. Reddy’s Laboratories Ltd (RDY): Investor Outlook Reveals 10.31% Potential Upside

Dr. Reddy’s Laboratories Ltd (RDY), a leading name in the healthcare sector, stands as a significant player within the specialty and generic drug manufacturing industry. With its roots firmly planted..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Look at Strong Buy Ratings and Revenue Growth in Healthcare

IQVIA Holdings, Inc. (IQV), a prominent player in the healthcare sector, is drawing significant attention from investors with its robust market presence and consistent revenue growth. With a market cap..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Natera, Inc. (NTRA) Stock Analysis: A Healthcare Pioneer with 37.7% Revenue Growth and Strong Buy Ratings

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector, stands out with a remarkable 37.7% revenue growth and a solid consensus of buy ratings. Specializing in the diagnostics..

HCA Healthcare, Inc. (HCA) Stock Analysis: Examining Growth Potential and Analyst Sentiment

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable entity in the U.S. healthcare sector, with a significant market capitalization of $92.92 billion. As a leading provider of healthcare services,..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 13.36% Potential Upside Amidst Mixed Financial Signals

As the healthcare sector continues to evolve in a rapidly changing global landscape, Viatris Inc. (NASDAQ: VTRS) emerges as a notable contender. With a market capitalization of $18.75 billion and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds